Why did my lichen planus pigmentosus worsen after cataract surgery and how should it be managed?

Lichen Planus Pigmentosus Aggravation Post-Cataract Surgery

The aggravation of your lichen planus pigmentosus (LPP) after cataract surgery is likely due to the Koebner phenomenon—trauma-induced disease activation—and should be managed with topical corticosteroids combined with systemic immunosuppression if ocular involvement is present.

Why LPP Worsened After Surgery

The surgical trauma from cataract surgery can trigger the Koebner phenomenon, where LPP lesions develop or worsen at sites of physical injury. This is a well-recognized feature of lichen planus variants. Additionally, the inflammatory cascade from surgery may have systemically activated your underlying autoimmune condition.

Critical consideration: If you're experiencing ocular symptoms (conjunctivitis, burning, blurred vision, or punctate keratitis), this represents ocular lichen planus—a serious complication that can lead to permanent visual impairment if untreated 1.

Immediate Assessment Required

Look specifically for:

• Ocular surface inflammation: conjunctival hyperemia, punctate keratitis, meibomian gland dysfunction
• Mucocutaneous involvement: oral ulcers, skin plaques, nail changes
• Visual symptoms: blurred vision, burning sensation, photophobia

The recent 2025 case report demonstrates that ocular lichen planus can develop 3 months post-cataract surgery and requires urgent interdisciplinary management 1.

Management Algorithm

If Ocular Involvement is Present (High Priority)

Initiate systemic immunosuppression immediately to prevent irreversible scarring and vision loss:

• Azathioprine 100 mg/day combined with short-course oral corticosteroids
• This regimen achieved substantial improvement within 4 months with sustained remission at 1 year 1
• Topical hydrocortisone for corneal involvement 2
• Urgent ophthalmology and dermatology co-management

If Only Cutaneous LPP Aggravation (No Ocular Symptoms)

1. First-line: Topical corticosteroids (moderate to high potency)

   • Apply to affected areas once daily
   • Monitor for treatment response over 4-6 weeks

2. Second-line (if resistant): Topical calcineurin inhibitors (pimecrolimus, tacrolimus)

   • Note: May cause irritation requiring reduced application frequency 3

3. Third-line (treatment-resistant cases):

   • Topical ruxolitinib (JAK inhibitor) showing emerging promise 4
   • Q-switched Nd:YAG laser (1064 nm, mean fluence 3.1 J/cm², 6 sessions) with 75% achieving moderate to complete clearance 5
   • Picosecond lasers also effective with conservative parameters 5

Critical Pitfalls to Avoid

⚠️ Do not dismiss ocular symptoms as routine post-operative inflammation—ocular lichen planus mimics other cicatrizing conjunctivitides and requires specific immunosuppressive treatment, not just lubricants or mild steroids 1.

⚠️ Avoid aggressive laser parameters initially—one case of koebnerized vitiligo has been reported with laser therapy 5. Start conservatively.

⚠️ Long-term topical corticosteroid use on genital/sensitive skin carries risks of atrophy and should be monitored 4.

Evidence Quality Note

The provided guidelines 6, 7 address lichen sclerosus, not lichen planus pigmentosus—these are distinct conditions and those recommendations do not apply here. The most relevant and recent evidence comes from the 2025 case report documenting post-cataract surgery ocular lichen planus 1, which directly parallels your situation and provides the strongest guidance for management.

Long-Term Monitoring

• Ophthalmology follow-up every 3-6 months if any ocular involvement
• Dermatology assessment for disease activity and treatment response
• LPP is chronic and treatment-resistant in many cases, requiring ongoing management 3
• Combination regimens (topical + systemic or topical + procedural) often yield better outcomes than monotherapy 8, 5